|
Volumn 39, Issue 4, 2002, Pages 291-297
|
Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma
a a a |
Author keywords
Asthma; Capsaicin; Cough; Cough Variant asthma; Leukotriene receptor antagonists; Leukotrienes; Zafirlukast
|
Indexed keywords
BECLOMETASONE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
BUDESONIDE;
CAPSAICIN;
CORTICOSTEROID;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIPHENHYDRAMINE;
FLUTICASONE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
LORATADINE;
METHACHOLINE;
ORCIPRENALINE;
PSEUDOEPHEDRINE;
SALBUTAMOL;
SALMETEROL;
TRIAMCINOLONE;
ZAFIRLUKAST;
ADULT;
ASTHMA;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
DOUBLE BLIND PROCEDURE;
DRUG MECHANISM;
HUMAN;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY EPITHELIUM;
TREATMENT FAILURE;
ADULT;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
BRONCHIAL PROVOCATION TESTS;
CAPSAICIN;
COUGH;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
LEUKOTRIENE ANTAGONISTS;
MALE;
MIDDLE AGED;
TOSYL COMPOUNDS;
TREATMENT OUTCOME;
|
EID: 0036094767
PISSN: 02770903
EISSN: None
Source Type: Journal
DOI: 10.1081/JAS-120002285 Document Type: Conference Paper |
Times cited : (155)
|
References (19)
|